Literature DB >> 17342391

Hepatic glycogenosis: an underrecognized source of abnormal liver function tests?

Gregory S Sayuk1, Jill E Elwing, Mauricio Lisker-Melman.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17342391     DOI： 10.1007/s10620-006-9430-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  12 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  An approach to diagnosis of hepatic glycogenosis.

Authors:  B A Bharucha; A S Savliwala; G V Koppikar; G G Naik; N B Kumta
Journal:  Indian Pediatr       Date:  1984-11       Impact factor: 1.411

3.  Hepatomegaly and abnormal liver tests due to glycogenosis in adults with diabetes.

Authors:  R Chatila; A B West
Journal:  Medicine (Baltimore)       Date:  1996-11       Impact factor: 1.889

4.  Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients.

Authors:  S Daniel; T Ben-Menachem; G Vasudevan; C K Ma; M Blumenkehl
Journal:  Am J Gastroenterol       Date:  1999-10       Impact factor: 10.864

5.  Hepatic glycogenosis: reversible hepatomegaly in type 1 diabetes.

Authors:  C F Munns; R B McCrossin; M J Thomsett; J Batch
Journal:  J Paediatr Child Health       Date:  2000-10       Impact factor: 1.954

6.  Histologic and electron-microscopic liver changes in diabetic children.

Authors:  G Lorenz; G Bärenwald
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1979-12

7.  Liver glycogenosis as early manifestation in type 1 diabetes mellitus.

Authors:  L Carcione; F Lombardo; M F Messina; M Rosano; F De Luca
Journal:  Diabetes Nutr Metab       Date:  2003-06

8.  Hepatic injury associated with diphenylhydantoin therapy. A clinicopathologic study of 20 cases.

Authors:  F G Mullick; K G Ishak
Journal:  Am J Clin Pathol       Date:  1980-10       Impact factor: 2.493

Review 9.  The pathologist's approach to the diagnosis of metabolic disease.

Authors:  C Ridaura-Sanz
Journal:  Pathol Res Pract       Date:  1994-12       Impact factor: 3.250

10.  The prevalence and etiology of elevated aminotransferase levels in the United States.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864
View more
  6 in total

1.  Glycogenic hepatopathy as a cause of severe deranged liver enzymes in a young patient with type 1 diabetes mellitus.

Authors:  Kalliopi Azariadis; Nikolaos K Gatselis; George K Koukoulis; Georgios N Dalekos
Journal:  BMJ Case Rep       Date:  2019-03-20

Review 2.  Hepatic glycogenosis: An underdiagnosed complication of diabetes mellitus?

Authors:  María Teresa Julián; Núria Alonso; Isabel Ojanguren; Eduarda Pizarro; Enric Ballestar; Manel Puig-Domingo
Journal:  World J Diabetes       Date:  2015-03-15

Review 3.  Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.

Authors:  Robert J Fontana
Journal:  Gastroenterology       Date:  2013-12-31       Impact factor: 22.682

Review 4.  Diagnosis of hepatic glycogenosis in poorly controlled type 1 diabetes mellitus.

Authors:  Stefania Giordano; Antonio Martocchia; Lavinia Toussan; Manuela Stefanelli; Francesca Pastore; Antonio Devito; Marcello G Risicato; Luigi Ruco; Paolo Falaschi
Journal:  World J Diabetes       Date:  2014-12-15

Review 5.  Glycogenic hepatopathy: A narrative review.

Authors:  Jagannath M Sherigar; Joline De Castro; Yong Mei Yin; Debra Guss; Smruti R Mohanty
Journal:  World J Hepatol       Date:  2018-02-27

6.  Hepatocellular Glycogen Accumulation in the Setting of Poorly Controlled Type 1 Diabetes Mellitus: Case Report and Review of the Literature.

Authors:  Atinuke Aluko; Ikponmwosa Enofe; Jacob Burch; Julie Yam; Nazia Khan
Journal:  Case Reports Hepatol       Date:  2020-02-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.